Načítá se...
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Kinase gene fusions are important drivers of oncogenic transformation and can be inhibited with targeted therapies. Clinical grade diagnostics using RNA sequencing to detect gene rearrangements in solid tumors are limited, and the few that are available require prior knowledge of fusion break points...
Uloženo v:
| Vydáno v: | J Mol Diagn |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Investigative Pathology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5975628/ https://ncbi.nlm.nih.gov/pubmed/28802831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2017.05.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|